Company story

PhD in Molecular Biology at the University Hospital in Zürich. Worked as Head of a Clinical Research Laboratory in Germany for international IVD- and MD clinical and technical studies; providing an excellent scientific and regulatory as well as customer understanding of the laboratory market.

PhD in Computer Science, MBA in Entrepreneurship; experience of more than 15 years in agile software development and leading software developers. First-hand start-up knowledge, coordinating all financial and entrepreneurial aspects.

PhD in Governance, MBA in Change-Management and M.Sc. in IVD- and MD regulatory affairs; worked more than ten years for a leading German Think Tank and headed the strategy development of a clinical research organisation. Responsible for business development and sales & marketing.

Constanze Ulmer-Eilfort is an attorney-at-law, admitted in Germany and New York, specializing on intellectual property, with a strong focus on the Life Sciences industry, advising biotech and pharmaceutical companies on collaboration and licensing agreements. She has been a partner with Baker McKenzie for 30 years, and was Managing Partner of the German and Austrian offices from 2012 to 2017 and member of the Global Executive Committee from 2017 to 2021. She was Chair of the Global Policy Committee, Chair of the Global Financial Committee and Chair of the Global Diversity and Inclusion Committee, and Chair of the EMEA Region. Constanze Ulmer-Eilfort is living in Munich and Rome.

Director of Business creation and member of the Executive Team of EIT Health, Kurt is also leading the Health accelerator, and acting as Co-Managing Director of EIT Health Services and Investment GmbH. Previously, Kurt has founded and directed the Central Institute of Healthcare Engineering at FAU, as well as several spin-offs and companies, being currently vice-chairman of the supervisory board of ESTW AG, a company with nearly € 200M revenue and 500+ employees. Kurt holds a Doctorate from FAU involving TU Munich and Johns Hopkins University, USA, and an MBA from THD involving Santa Clara University in Silicon Valley.

Dr. Ursula Redeker is former Spokesperson of the Executive Board of Roche Diagnostics GmbH and former Managing Director of Roche Deutschland Holding GmbH. Senior executive in pharmaceutical and diagnostics industry with more than 25 years of experience (biotech and global corporations) and more than 15 years in senior leadership roles. Strong strategic leader with track record in leading continuous change and successful focus on finding and developing best talent

Member of the Executive Board Sales / R&D SARSTEDT AG & CO. KG

Valentin Piëch is a Managing Director at Zurich based life sciences venture capital firm VP Venture Partners and has a background in venture capital, science, and technology. Prior to founding VP Venture Partners, he was Investment Director at the VC firm BioMedPartners, and previously worked at Nextech Invest, a VC focusing on oncology. In addition, he is a private investor in a number of startup and growth companies. Valentin holds a PhD in Neuroscience from the Rockefeller University, a Master degree in Cognitive and Neural Systems from Boston University and a Master Degree in Mechanical and Process Engineering from the Federal Institute of Technology in Zurich (ETH).